Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Hypoallergenic moisturizing cream for dermatitis and dehydrated skin espcially formulated for sensitive skin, thanks to the total absence of preservayives and perfumes More
Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jun 2006 - 434 pages - $2,495
Sep 2011 - 117 pages - $500
Nov 2011 - 100 pages - $3,500
Jul 2011 - 96 pages - $3,835
Mar 2011 - 5 pages - $500
Oct 2011 - 89 pages - $3,500
Jun 2011 - 77 pages - $1,000
Nov 2009 - 142 pages - $2,350
Dec 2007 - 49 pages - $495
Nov 2010 - 64 pages - $1,495
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us